OR WAIT 15 SECS
LGC has launched a new business unit, Health Sciences, which combines the group?s sport, food, consumer safety and pharmaceutical testing activities within a single entity.
LGC has launched a new business unit, Health Sciences, which combines the group’s sport, food, consumer safety and pharmaceutical testing activities within a single entity. The unit offers supplement customers in-house testing from banned substances to additives/compositional testing.
The launch follows LGC’s acquisition of drug surveillance, doping control and research company, HFL Sport Science in December 2010. This acquisition extended and complemented the company’s analytical service offerings allowing the companies to provide a testing programme for foodstuffs, ingredients and nutritional supplements.
David Hall, CEO of HFL Sport Science and director of Health Sciences at LGC, commented: “By bringing together the knowledge, expertise and instrumentation of LGC and HFL into a single new business entity called Health Sciences we believe that this will bring significant benefit to our customers. In addition, this will open up a range of market opportunities in the UK, Europe and the USA.”
The new unit’s range of testing services include banned substances (prohibited by the World Anti-Doping Agency); nutritional biomarkers; nutritional analysis; and contaminants and residues.
For more information visit www.lgc.co.uk